John B. Pracyk, MD, PhD, MBA Inaugurated as MAPS President – Americas Region
The Medical Affairs Professional Society (MAPS), the premier non-profit global society of Medical Affairs professionals, is honored to announce the appointment of John B. Pracyk, MD, PhD, MBA, as President of the Americas Region. Recently, Dr. Pracyk was appointed to the MAPS Board of Directors and serves as the Integrated Leader for Preclinical & Clinical Research and Medical Affairs (PCM) for DePuy Synthes Spine (Johnson & Johnson Medical Device Companies). He brings to the MAPS organization a wealth of experience including as a basic and clinical science investigator, a spine fellowship trained neurological surgeon, a multidisciplinary care program architect, and more recently as a Medical Affairs leader from within the MedTech (Medical Devices) sector.
“Our objective is that of empowerment. We want to empower Medical Affairs professionals worldwide through content, through skills, and most meaningfully through connectivity,” Dr. Pracyk says.
Dr. Pracyk holds a Bachelor of Science in Zoology and also fulfilled the degree requirements for Bachelor of Arts in Music from Duke University where he concurrently earned his Doctor of Medicine (MD) and Doctor of Philosophy (PhD in Pharmacology & Cancer Biology) degrees though its Medical Scientist Training Program. He was competitively awarded pre- and postdoctoral research fellowships at Cambridge University and the National Institutes of Health. Dr. Pracyk completed his Neurological Surgery residency at The George Washington University and his spine fellowship at University of Iowa Hospitals and Clinics.
Dr. Pracyk is a diplomate of the American Board of Neurological Surgery, a Fellow of the American Association of Neurological Surgeons, a Fellow of the American College of Surgeons, and a member of the American College of Healthcare Executives. Dr. Pracyk completed a Physician Executive Healthcare Master of Business Administration (MBA) at The Haslam College of Business of the University of Tennessee and then joined DePuy Synthes in February 2016 as Franchise Medical Director for Spine responsible for the innovation pipeline. In September 2017 he was appointed Franchise Medical Leader where he continued to provide deep clinical insights to accelerate meaningful innovation and drive value and safety for spine patients worldwide. In 2018 his role was further expanded in scope and responsibility as the new Integrated Leader of Preclinical and Clinical Research and Medical Affairs for the DePuy Synthes Spine platform.
“We are honored to include John in this highly visible leadership role, where he is able to exemplify the expanding goals of Medical Affairs professionals as practiced within the medical technology industry to our organization that has been predominantly composed of premier thought leaders from within the space of biopharmaceutical innovation,” says Travis Hege, CEO of MAPS.
In fact, it was after attending a session on health care compliance at the 2018 Global Annual MAPS Meeting led by Ann Ford, Esq. that Dr. Pracyk recognized the under-representation of medical technology within the organization and discussed this growth opportunity with MAPS executive leadership.
“John identified a blind spot for us,” Hege says.
“At the first encounter I somewhat challenged Travis on the MedTech representation and instead of pushing back, he put his arm around me and helped me push the entire organization forward,” Dr. Pracyk remembered. At the next Global Annual Meeting in 2019, Dr. Pracyk shared the stage with MAPS Board Chair Charlotte Kremer, MD of Astellas Pharmaceuticals to explore the similarities and differences between the Medical Affairs structure and practice within biopharmaceutical and medical technology industries. For the past two years, Dr. Pracyk has led the MAPS MedTech Focus Area Working Group and has contributed content across multiple formats, including the Inaugural MAPS Podcast in December of 2018.
As the newly appointed President of the Americas Region, Dr. Pracyk will guide the growth of the largest region of the MAPS organization and collaborate with MAPS leadership to provide direction for the profession as a whole during a time when Medical Affairs is clearly elevated in strategic importance alongside Research & Development and Commercial colleagues from both the biopharmaceutical and medical technology industries.
“I find it particularly fascinating that MAPS as an organization and myself as a relative newcomer to the Medical Affairs profession have been going through a separate but mutually synergistic, transformation,” Dr. Pracyk says. “I’m humbled by the privilege of being in the position to alter the trajectory as well as the velocity of MAPS growth as an organization, while the Medical Affairs profession concurrently ascends to the next echelon. Simply put, MAPS is the glue, the catalyst, and foremost the crucible that is nurturing the spark of this growth moment for Medical Affairs.”
The MAPS organization, on behalf of its staff, leadership and members, looks forward to working closely with Dr. Pracyk as Medical Affairs professionals collaborate to advance the organization, the profession, and, ultimately, patients who depend on the safety and effectiveness of emerging drugs and technologies.